SCHEMBL20198982

SCHEMBL20198982

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc(-c4ccc5c(c4)-c4oc6ccccc6c4C54c5ccccc5-c5ccccc54)cc3)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 5/20 0.34
PLA2G4A P47712 5/20 0.34
PLA2G10 O15496 1/20 0.33
PDK2 Q15119 1/20 0.33
ALOX5 P09917 1/20 0.32
CYP3A4 P08684 3/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
TP53 P04637 2/20 0.32
ABCB1 P08183 2/20 0.32
AR P10275 2/20 0.32
CYP1B1 Q16678 2/20 0.32
CA9 Q16790 2/20 0.32
ADORA3 P0DMS8 2/20 0.32
DDR2 Q16832 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20175023 0.95 PLA2G2A (0.32) PLA2G2APLA2G4APLA2G10PDK2
SCHEMBL20175231 0.94 PDK2 (0.33) PLA2G2APLA2G4APDK2ALOX5
SCHEMBL22326529 0.93 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10PDK2ALOX5
SCHEMBL20198963 0.92 PDK2 (0.30) PDK2
SCHEMBL20175007 0.92 PDK2 (0.34) PLA2G2APLA2G4APLA2G10PDK2
SCHEMBL20175024 0.92 PDK2 (0.34) PLA2G2APLA2G4APLA2G10PDK2
SCHEMBL20174976 0.91 PDK2 (0.30) PLA2G2APLA2G4APDK2
SCHEMBL20174788 0.91 PDK2 (0.36) PLA2G2APLA2G4APLA2G10PDK2ALOX5
SCHEMBL20198961 0.91 PDK2 (0.36) PLA2G2APLA2G4APLA2G10PDK2ALOX5
SCHEMBL23592407 0.91 PLA2G2A (0.34) PLA2G2APLA2G4APLA2G10CYP3A4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10781366-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-09-22 US disclosed
US-20180148639-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-31 US disclosed
US-20180148639-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10781366-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG PLA2G2A 4788/4885PLA2G4A 4802/4885PLA2G10 4732/4885
US-20180148639-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG PLA2G2A 4788/4885PLA2G4A 4802/4885PLA2G10 4732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.